Attached files

file filename
EX-99.5 - EX-99.5 - Arcadia Biosciences, Inc.rkda-ex995_12.htm
EX-99.4 - EX-99.4 - Arcadia Biosciences, Inc.rkda-ex994_92.htm
EX-99.3 - EX-99.3 - Arcadia Biosciences, Inc.rkda-ex993_11.htm
EX-99.1 - EX-99.1 - Arcadia Biosciences, Inc.rkda-ex991_10.htm
EX-23.2 - EX-23.2 - Arcadia Biosciences, Inc.rkda-ex232_9.htm
EX-23.1 - EX-23.1 - Arcadia Biosciences, Inc.rkda-ex231_8.htm
8-K/A - 8-K/A - Arcadia Biosciences, Inc.rkda-8ka_20210517.htm

Exhibit 99.2

 

 

 

 

 

 

 

REVER HOLDINGS, LLC

 

 

Condensed Consolidated Financial Statements

As Of March 31, 2021 And For The

Three Months Ended March 31, 2021

 

 

 

 

 

 

 


 

 

rever holdings, LLC

 

INDEX TO condensed CONSOLIDATED FINANCIAL STATEMENTS

 

 

Page

 

 

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS:

 

 

 

Unaudited Condensed Consolidated Balance Sheet

3

 

 

Unaudited Condensed Consolidated Statement of Operations

4

 

 

Unaudited Condensed Consolidated Statement of Cash Flows

5

 

 

Notes to the Unaudited Condensed Consolidated Financial Statements

6

 

 

 

 


 

 

Rever holdings, LLC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEET

 

 

 

March 31,

 

 

 

2021

 

ASSETS

 

 

 

 

Current assets

 

 

 

 

Cash and cash equivalents

 

$

533,342

 

Accounts receivable, net

 

 

446,139

 

Inventories

 

 

1,143,471

 

Prepaids and other current assets

 

 

114,911

 

Total current assets

 

 

2,237,863

 

 

 

 

 

 

Right-of-use asset

 

 

718,013

 

Property, plant and equipment, net

 

 

213,887

 

Intangible assets, net

 

 

60,033

 

Other assets

 

 

110,318

 

Total assets

 

$

3,340,114

 

 

 

 

 

 

LIABILITIES AND MEMBERS DEFICIT

 

 

 

 

Current liabilities

 

 

 

 

Accounts payable

 

$

782,499

 

Accounts payable - related party

 

 

5,558,349

 

Accrued and other current liabilities

 

 

456,539

 

Current portion of lease liabilities

 

 

192,608

 

Notes payable

 

 

248,396

 

Current Liabilities

 

 

7,238,391

 

 

 

 

 

 

Lease liabilities

 

 

525,405

 

Total liabilities

 

 

7,763,796

 

 

 

 

 

 

Commitments and Contingencies - Note 10

 

 

 

 

 

 

 

 

 

Member's deficit

 

 

 

 

Member's capital

 

 

661,000

 

Accumulated deficit

 

 

(5,084,683

)

Total members' deficit

 

 

(4,423,683

)

Total liabilities and members' deficit

 

$

3,340,113

 

 

See the accompanying notes to these unaudited condensed consolidated financial statements.

 

 

3


 

 

rever holdings, llc.

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

(unaudited)

 

 

 

Three months

 

 

 

ended March 31,

 

 

 

2021

 

Revenue

 

$

518,532

 

Cost of goods sold

 

 

1,318,257

 

Gross profit

 

 

(799,725

)

 

 

 

 

 

Operating expenses:

 

 

 

 

Sales and marketing

 

 

303,586

 

General and administration

 

 

434,466

 

Total operating expenses

 

 

738,052

 

Loss from operations

 

 

(1,537,777

)

 

 

 

 

 

Other income (expenses):

 

 

 

 

Other income

 

 

 

Other expense

 

 

(1,359

)

Total other expenses

 

 

(1,359

)

Net loss

 

 

(1,539,136

)

 

See the accompanying notes to these unaudited condensed consolidated financial statements.

 

 

4


 

 

rever holdings, llc.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(unaudited)

 

 

 

Three Months

 

 

 

Ended March 31,

 

 

 

2021

 

Cash flows from operating activities:

 

 

 

 

Net loss

 

 

(1,539,136

)

Adjustments to reconcile net loss to net cash provided operating activities:

 

 

 

 

Depreciation expense

 

 

18,021

 

Amortization of intangible assets

 

 

632

 

Change in operating assets and liabilities:

 

 

 

 

Accounts receivable

 

 

5,509

 

Inventories

 

 

346,051

 

Prepaids and other current assets

 

 

(96,513

)

Other assets

 

 

13

 

Accounts payable

 

 

(106,601

)

Accounts payable - related party

 

 

1,216,921

 

Accrued and other current liabilities

 

 

387,036

 

Lease liabilities

 

 

22,473

 

Net cash provided by operating activities

 

 

254,406

 

Cash flow from investing activities

 

 

 

 

Purchases of property, plant and equipment

 

 

(28,012

)

Net cash used in investing activities

 

 

(28,012

)

Net increase in cash and cash equivalents

 

 

226,394

 

Cash and cash equivalents, beginning of the year

 

 

306,948

 

Cash and cash equivalents, end of the year

 

$

533,342

 

 

See the accompanying notes to these unaudited condensed consolidated financial statements.

 

 

 

5


 

rever holdings, llc.

NOTES TO FINANCIAL STATEMENTS

 

 

Note 1: Description of Business Nature of Operations

 

On December 20, 2018 Rever Holdings, LLC. ("the Company", "Rever") was created by Left Coast Ventures, Inc. ("LCV") the sole member, as a holding company for recently registered Eko Holdings, LLC. ("Eko") and Lief Holdings, LLC. ("Lief").  Eko and Lief were created to manufacture brand development, and distribution CBD infused products including third party CBD infused products. Wholly owned, licensed, and/or distributed brands within the Rever's portfolio include: SoulSpring™ CBD, and Provault™ CBD.

 

Note 2: Summary of Significant Accounting Policies

 

Basis of Presentation

 

The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") and the accounting policies set out below have been applied. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations have been reflected herein.

 

Principles of Consolidation

 

The accompanying condensed consolidated financial statements include the assets, liabilities, revenue and expenses of all wholly-owned and majority-owned subsidiaries over which the Company exercises control and, when applicable, entities in which the Company has a controlling financial interest or is the primary beneficiary.  All intercompany balances and transactions have been eliminated.

 

Use of Estimates

 

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results may differ from these estimates.

 

Revenue Recognition

 

The Company recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services in accordance with ASU 2014-09, Revenue from Contracts with Customers ("Topic 606").  The Company enters into contracts that can include various products, which are generally capable of being distinct and accounted for as separate performance obligations.  Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities.  The revenue recognition policy is consistent for sales generated directly with customers and sales generated indirectly through solution partners and resellers.

 

Revenues are recognized upon the application of the following steps:

 

1. Identification of a contract or contracts with a customer;

2. Identification of performance obligation(s) in the contract;

3. Determination of the transaction price;

4. Allocation of the transaction price to the performance obligations in the contract; and

5. Recognition of revenue when, or as, the performance obligation is satisfied.

 

Contracts with customers are at the point of sale and while often include transfer multiple products to a customer; they do not require future obligations.  The Company generally considers each transaction as a separate performance obligation.  Products are generally sold without a right of return, except for the extremely rare instance of a significant product defect identified upon delivery, which is not considered a separate performance obligation.

 

The Company allocates the transaction price for each contract to each performance obligation based on the relative standalone selling price ("SSP") for each performance obligation.  The Company uses judgment in determining the

 

6


 

rever holdings, llc.

NOTES TO FINANCIAL STATEMENTS

 

SSP for products.  The Company typically determines an SSP range for its products which are reassessed on a periodic basis or when facts and circumstances change.  For all performance obligations (multiple products), the Company is able to determine SSP based on the observable prices of products sold separately in comparable circumstances to similar customers.

 

In certain instances, the Company may provide incentives and discounts.  The discounts are generally applied to promotional products.  The discounts are determinable and fixed at the inception of the contract and accounted for as a reduction of the purchase price. Contracts do not include a significant financing component.

 

The majority of customer contracts, which may be in the form of purchase orders, or contracts contain performance obligations for delivery of agreed upon products.  Typically, when a customer contract contains multiple performance obligations, satisfaction of these obligations occurs simultaneously, at a single point in time (or within the same accounting period).  Transfer of control typically occurs at the time of delivery and title and the risks and rewards of ownership have passed to the customer, and the Company has a right to payment.  Thus, the Company generally recognizes revenue upon delivery of the product.

 

All shipping and handling activities are performed before the customers obtain control of products and accounted for as cost of goods sold.

 

The Company does not have any customer contracts that contain future deliverables that meet the definition of unsatisfied performance obligations in accordance with Topic 606.

 

Leases

 

ASC 842, Leases ("ASC 842"), requires lessees to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases.  Under ASC 842, a lessee is required to recognize assets and liabilities for leases with terms of more than 12 months.  Lessor accounting remains substantially similar to current U.S. GAAP. ASC 842 also provides a package of transition practical expedients that allow an entity to not reassess (1) whether any expired or existing contracts contain a lease, (2) the lease classification of any expired or existing lease, and (3) initial direct costs for any existing lease.

 

Effective October 1, 2019, the Company adopted ASC 842 using the modified retrospective method. Under the available practical expedient, the Company accounts for the lease and non-lease components as a single lease component for all classes of underlying assets as both a lessee and lessor.  Further, the Company elected a short-term lease exception policy on all classes of underlying assets, permitting the Company to not apply the recognition requirements of ASC 842 to short-term leases (i.e. leases with terms of 12 months or less).

 

Right-Of-Use ("ROU") assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the corresponding obligation to make lease payments arising from the lease.  Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term.  Variable lease payments are not included in the calculation of the ROU asset and lease liability due to uncertainty of the payment amount and are recorded as lease expense in the period incurred.  As most of the leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.  The Company uses the implicit rate when readily determinable.  The lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

 

Note 3: Concentration of Credit Risk

 

Financial instruments that subject the Company to potential concentrations of credit risk consist principally of cash and trade accounts receivable.  The Company maintains its cash primarily in U.S. bank accounts, which at times may exceed federally insured limits.  At March 31, 2021, the Company did have approximately $29,500 uninsured cash and cash equivalents.

 

 

7


 

rever holdings, llc.

NOTES TO FINANCIAL STATEMENTS

 

 

There were four customers that accounted for more than 10% of the Company's accounts receivables as of
March 31, 2021.  There were three customers that accounted for more than 10% of the Company's revenue for the year ended March 31, 2021.

 

Note 4: Related Party Transactions

 

In the normal course of business, the Company enters into various unsecured and non-interest bearing transactions between related parties.  The majority of related party activity relates to operational funding requests and services provided.  Balance sheet netting is performed on an individual related party basis when the right of offset exists based on historical precedence.  

 

At March 31, 2021, the Company had amounts due to Left Coast Ventures (parent company), of $5,558,349 for short-term working capital advances which is recorded in "Accounts payable – related party" on the accompanying balance sheet and are considered short-term.

 

Note 5: Inventories

 

Inventories consist of raw materials and finished goods. Finished goods consist of distillates & crude oil extracted from cannabis plant material as well as cannabis flower held for resale, and raw materials consist of the harvested cannabis plant material.

 

At March 31, 2021, inventories consisted of the following:

 

 

 

March 31,

2021

 

Finished goods

 

$

1,143,471

 

Total inventory

 

$

1,143,471

 

 

Note 6: Property, Plant and Equipment

 

At March 31, 2021, property, plant and equipment, net consisted of the following:

 

Computer Equipment

 

$

10,358

 

Machinery and Equipment

 

 

235,072

 

Leasehold Improvements

 

 

69,300

 

Total

 

 

314,730

 

Less: accumulated depreciation

 

 

(100,843

)

 

 

$

213,887

 

 

For the three months ended March 31, 2021 depreciation expense was $18,021.

 

Note 7: Intangible Assets

 

At March 31, 2021, intangible assets, net consisted of the following:

 

Tradenames

 

$

91,000

 

Less: Accumulated amortization

 

 

(30,967

)

 

 

$

60,033

 

 

Amortization expense for the three months ended March 31, 2021 was $632. Estimated amortization expense for the remaining nine months ending December 31, 2021 is $5,688 and each of the ensuing years through December 31, 2029 is $7,584 per year (except for 2029 which will be $1,264).

 

 

8


 

rever holdings, llc.

NOTES TO FINANCIAL STATEMENTS

 

 

Note 8: Leases

 

Operating Leases

 

The Company leases its business facilities from third parties under operating agreements. The leases expire under various terms through 2029.

 

As of March 31, 2021, the Company’s right-of-use assets were $718,013, the Company’s current maturities of operating lease liabilities were $192,608, and the Company’s noncurrent lease liabilities were $525,405.

 

The table below presents lease related terms and discount rates as of March 31, 2021.

 

Weighted average lease term

 

 

 

 

Operating leases

 

 

41

 

Weighted average discount rate

 

 

 

 

Operating leases

 

 

11.36

%

 

The reconciliation of the maturities of the operating leases to the lease liabilities recorded in the condensed consolidated balance sheet as of March 31, 2021 are as follows:  

 

For the three months ended March 31, 2021, total lease expenses was $62,236.

 

Note 9: Commitments and Contingencies

 

Litigation

 

In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. Legal fees for such matters are expensed as incurred and the Company accrues for adverse outcomes as they become probable and estimable.  Currently, there is no pending litigation against the Company.    

 

Contractual Agreements with Cultivators

 

The Company enters into several agreements with cultivators whereby the Company splits the proceeds from the sale of the finished goods (i.e., distillates/oil) produced from the cultivators’ supplied raw materials which represents the cost of the raw materials used to produce the finished goods.  The Company is unable to determine a reasonable estimate to record the cost of these raw materials as inventory due to certain variables. These variables include the quantity of distillates and oil extracted from cultivators’ supplied raw materials, the quality of distillates and oil, and market price fluctuations, among others.  The Company records the cost of these materials as cost of goods sold in the same accounting period that revenue is recorded and considers these agreements to be similar to a royalty arrangement.

 

Note 10: Subsequent Events

 

The Company has evaluated subsequent events through July 28, 2021, the date the condensed consolidated financial statements were available to be issued.

 

On May 14, 2021, the PPP Loan from May 3, 2020, in the amount of $248,396 was forgiven by the SBA and the Company recorded full amount as other income related to the forgiveness of the PPP Loan.

 

On May 17, 2021, the Company entered into an Asset Purchase Agreement ("Transaction") to sell the operating assets and corresponding liabilities of the company combined with the coconut water business line of products, including certain assets and liability of the business line to a third party ("Buyer").  Consideration for the Transaction amounted to $4,000,000 in cash and 827,400 shares of the Buyer's common stock.

 

9